ChemoCentryx Stock Price (NASDAQ:CCXI)

Add to My Stocks
$12.37 $0.54 (4.56%) CCXI stock closing price Sep 20, 2018 (Closing)
Prev Close* : $11.83
Market Cap:
$566.21M
Day Low: $11.8
52 Week Low: $5.42
Open: $11.89
Volume: -
Day High: $12.44
52 Week High: $15.08
Dividend:
0.00

Latest Stock Market News

Latest Articles

ChemoCentryx News - From Partners

Bull of the Day: ChemoCentryx (CCXI)   by Zacks on Jun 22, 2018

CCXI Stockcharts

View CCXI PE ratio, PS ratio stocks charts and compare with peers.
CCXI Chart
Note: Compare ChemoCentryx stock price history with the index and industry peers.

ChemoCentryx Valuation

PE ratio
(price earnings ratio)
34.79
PS ratio (
price to sales ratio
)
7.25
PB ratio (
price to book ratio
)
13.83

ChemoCentryx Returns

ROE
(return on equity)
40%

ChemoCentryx Financial Ratios

Asset Turnover
0.31
Receivables Turnover
7.53
Debt to Equity
0.51
Dividend Yield
0%

CCXI Industry Peers

Company Price Change (%)
Optinose Inc (OPTN)13.660.01 (0.07%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Incyte (INCY)67.250.57 (0.84%)
Johnson & Johnson (JNJ)140.460.08 (0.06%)
Merck (MRK)69.980.44 (0.62%)
Zalicus (EPRSQ)00 (0%)
Bristol-myers Squibb (BMY)60.80.68 (1.11%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

ChemoCentryx Inc Stock News - Partner Headlines

ChemoCentryx Financial Statements

income statement20172016201520142013
Net Sales or Revenues82.49M11.93M--6.06M
Net Income--39.96M-47.3M-46.92M-38.67M
Total Operating Expense65.99M52.65M47.68M47.39M45.17M
View ChemoCentryx income statement
balance sheet20172016201520142013
Total Assets189.32M155.87M78.15M116.98M152.42M
Total Liabilities110.06M105.98M5.64M8.37M7.11M
Shareholders Equity79.26M49.88M72.5M108.6M145.3M
View ChemoCentryx balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-22.29M70.04M-2.49M1.7M-3.52M
Net Cash from (used by) Operating Activities4.87M39.14M-39.32M-34.31M-33.31M
Increase (Decrease) in Prop Plant And Equipment-0.72M-0.3M-0.21M-0.35M-0.55M
View ChemoCentryx cash flow statement

ChemoCentryx Stock Message Board

An investor needs to spend $12.37 to buy CCXI stock, as the closing ChemoCentryx stock price is $12.37. Looking at ChemoCentryx market capitalization, which currently stands at $566.21M, we can say that CCXI stock is a Small Cap stock. ChemoCentryx valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy CCXI stock than sell it, then ChemoCentryx stock price goes up. Conversely, if more investors wanted to sell CCXI stock than buy it, there would be greater supply than demand, and the stock price would fall. 244,332 shares were traded with a closing stock price of $12.37 as of Sep 20, 2018, as can be seen from ChemoCentryx stock quote. One can view ChemoCentryx stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. ChemoCentryx stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking ChemoCentryx stock price history.